Background: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candidate. The aim of this study was to analyze the PspA family and clade distribution among 112 Spanish pneumococci representatives of dominant clones among patients with invasive disease (n = 66) and nasopharyngeal healthy carriage in children (n = 46). Results: PspA family 2 was predominant among invasive (63.6%) and carriage (54.3%) pneumococcal isolates. No PspA family 3 isolates were detected and only one strain was PspA negative. Although four clonal complexes contained strains of different clades, a clear association between clade and multi locus sequence typing results was found. Clades 1, 3 and 4 were associated with a wide variety of se...
To estimate the invasive disease potential of serotypes and clones circulating in Portugal before ex...
There is scarce information about pneumococcal carriage among healthy children in Malaysia. The naso...
The protection against pneumococcal infections provided by currently available pneumococcal polysacc...
Background: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candi...
Background: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candi...
Objectives: We aimed to analyse the clinical epidemiology and genetic diversity of invasive pneumoco...
Objectives:We aimed to analyse the clinical epidemiology and genetic diversity of invasive pneumococ...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
AbstractStreptococcus pneumoniae resides on mucosal surfaces in the nasopharynx, where selection for...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
The diverse pneumococcal diseases are associated with different pneumococcal lineages, or clonal com...
Six drug-resistant Streptococcus pneumoniae clones were previously identified from day care centers ...
Pneumococcal surface protein A (PspA) elicits protection in mice against fatal bacteremia and sepsis...
To estimate the invasive disease potential of serotypes and clones circulating in Portugal before ex...
There is scarce information about pneumococcal carriage among healthy children in Malaysia. The naso...
The protection against pneumococcal infections provided by currently available pneumococcal polysacc...
Background: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candi...
Background: PspA is recognized as a major pneumococcal virulence factor and a possible vaccine candi...
Objectives: We aimed to analyse the clinical epidemiology and genetic diversity of invasive pneumoco...
Objectives:We aimed to analyse the clinical epidemiology and genetic diversity of invasive pneumococ...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
AbstractStreptococcus pneumoniae resides on mucosal surfaces in the nasopharynx, where selection for...
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective ...
The aim of this study was to study the serotypes and clonal diversity of pneumococci causing invasiv...
The diverse pneumococcal diseases are associated with different pneumococcal lineages, or clonal com...
Six drug-resistant Streptococcus pneumoniae clones were previously identified from day care centers ...
Pneumococcal surface protein A (PspA) elicits protection in mice against fatal bacteremia and sepsis...
To estimate the invasive disease potential of serotypes and clones circulating in Portugal before ex...
There is scarce information about pneumococcal carriage among healthy children in Malaysia. The naso...
The protection against pneumococcal infections provided by currently available pneumococcal polysacc...